Connection

DAVID LONARD to Heterografts

This is a "connection" page, showing publications DAVID LONARD has written about Heterografts.
Connection Strength

0.038
  1. The REG? inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells. Nat Commun. 2020 08 06; 11(1):3904.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.